Skip to content

Total Equity at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$24.13B-4.4%
IAR
Integra LifeSciencesIART
$1.04B-31.6%
Solventum logo
SolventumSOLV
$4.97B+52.3%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$435.19M-5.0%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$18.84M-5.7%
Xtant Medical Holdings logo
Xtant Medical HoldingsXTNT
$48.6M+10.8%

Other financials

Income statement

See full
Revenue$27.8M+18.6%
Gross profit$25.9M+19.8%
Operating income$2.6M+221%
Net income$459.0K+113%
EPS (diluted)$0.05+112%

Balance sheet

See full
Cash & equivalents$13.6M-34.3%
Total debt$48.4M+8.2%
Total assets$69.3M-28.1%

Cash flow

See full
Operating cash flow-$2.5M-23.3%
CapEx$43.8K-97.5%
Free cash flow-$2.5M+32.6%

Valuation

See full
Market cap$216.18M-9.7%
Enterprise value$250.95M-6.5%
P/S-0.5×

Profitability

See full
Gross margin92.9%+1.8pp
Operating margin6.1%+5.1pp
Net margin-31.2%-93.4pp
FCF margin-9.8%-3.5pp

Returns & leverage

See full
Return on equity-153.7%-199pp
Debt / equity6.9×+5.7×
Current ratio2.3×-0.5×

Where this comes from

Reported directly by Sanara MedTech Inc. in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Sanara MedTech Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sanara MedTech Inc.'s total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sanara MedTech Inc.'s total equity?
Sanara MedTech Inc. (SMTI) reported total equity of $7.03M in Q1 2026.
How has Sanara MedTech Inc.'s total equity changed year-over-year?
Sanara MedTech Inc.'s total equity decreased by 80.8% year-over-year, from $36.67M to $7.03M.
What is the long-term trend for Sanara MedTech Inc.'s total equity?
Over 5 years (2020 to 2025), Sanara MedTech Inc.'s total equity has grown at a -0.7% compound annual growth rate (CAGR), from $6.15M to $5.94M.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.